Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
501 n. Highland Dr
Cedar Falls, IA 50613Phone+1 319-231-1728
Summary
- Joginder Singh, MD is a healthcare provider situated in Waterloo, IA with a specialty in Oncology, and further expertise in Hematologic Oncology. Dr. Singh obtained a vast portion of his education from the University of Arkansas for Medical Sciences and Albert Einstein College of Medicine, where he completed fellowships in Hematology and Medical Oncology. He went on to serve as a Hematologist/Oncologist at MercyOne North Iowa Medical Center from 2016 -2020. Dr. Singh has noteworthy experience with thrombotic disorders, general/benign hematology, and anemia. He has contributed to medical publications, notably "Anti‐myeloma activity of pamidronate in vivo," and conducted clinical trials regarding Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer.
Education & Training
University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 1997 - 1998
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1996 - 1997
Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1996
New York-Presbyterian/QueensResidency, Internal Medicine, 1993 - 1994
Harlem Hospital CenterResidency, Internal Medicine, 1990 - 1993
Government Medical College AmritsarClass of 1979
Certifications & Licensure
FL State Medical License 2020 - 2026
TX State Medical License 2020 - 2026
IA State Medical License 1998 - 2025
MN State Medical License 2023 - 2025
CA State Medical License 2020 - 2022
AZ State Medical License 2020 - 2021
IL State Medical License 2020 - 2021- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 74 citationsAnti‐myeloma activity of pamidronate in vivoMadhav V. Dhodapkar, Joginder Singh, Jayesh Mehta, Athanasios Fassas, K. R. Desikan
British Journal of Haematology. 1998-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
